Area of Research: High Grade Serous Ovarian Cancer
2023 Grant Recipients
- Brooke Howitt, MD, Stanford University Early Career Investigator GrantIdentifying the Cell of Origin for High- Grade Serous Carcinoma
2022 Grant Recipients
- Lindsay Brubaker, MD, University of Colorado - Denver Early Career Investigator GrantTargeting Chromobox 2 to Overcome Macrophage-induced Immune Suppression
- Sohrab Shah, PhD, Memorial Sloan Kettering Cancer Center Collaborative Research Development GrantInferring Mutational Processes and Patient Stratification From Standard-of-Care Clinical Imaging
- Zelei Yang, PhD, Dana Farber Cancer Institute Mentored Investigator GrantRe-engaging the Anti-tumor Immune Response Against Ovarian Cancer
- Imade Williams, PhD, Indiana University Mentored Investigator GrantTargeting MYC-HSF1 co-Amplification in High Grade Serous Ovarian Cancer
- Amrita Salvi, PhD, The University of Illinois at Chicago Mentored Investigator GrantInvestigating the mechanism of action of PHY34 in HGSOC
- Pamela Rojas de Santiago, PhD, University of Pennsylvania Mentored Investigator GrantInvestigating the Therapeutic Potential of CRABP2 in HGSOC
2021 Grant Recipients
- Anne M. van Harten, PhD, Thomas Jefferson University Mentored Investigator GrantTargeted MDM2 Degradation as a Novel Treatment for Ovarian Cancer
- Sammy Ferri-Borgogno, PhD, MD Anderson Cancer Center Mentored Investigator GrantSpatially-Resolved Cellular and Transcriptome Analyses of Ovarian Cancer
- Arun Kanakkanthara, PhD, Mayo Clinic Early Career Investigator GrantExploiting a Metabolic Dependency of PARPinhibitor-Resistant Ovarian Cancer
- Liya Ding, PhD, Dana Farber Cancer Institute Early Career Investigator GrantTargeting Therapeutic Resistance to PARP Inhibition in Ovarian Cancer
- Sandra Cascio, PhD, Magee-Womens Research Institute Early Career Investigator GrantEGFL6 as a New Regulator of Myeloid Cell Expansion and Function in HGSOC
- Ivan Ahel, PhD, University of Oxford Collaborative Research Development GrantExploiting PARP-Modulating Enzymes in Ovarian Cancer Therapy
- Xueyang Yu, PhD, Massachusetts Institute of Technology Mentored Investigator GrantMacrophage Control of the Microenvironment Drives HGSOC Progression
2020 Grant Recipients
- David Chapel, MD, Brigham and Women’s Hospital Mentored Investigator GrantThe Migratory Precursor and Serous Carcinogenesis
- James Duncan, PhD, Fox Chase Cancer Center Early Career Investigator GrantExploring PROTAC-Mediated Degradation of BRD4 in Ovarian Cancer
- Sudipto Ganguly, PhD, Johns Hopkins University Early Career Investigator GrantCharacterizing a Novel Checkpoint Axis in High-Grade Serous Ovarian Cancer
- Brooke Howitt, MD, Stanford University Early Career Investigator GrantIdentifying the Cell of Origin for Ovarian High-Grade Serous Carcinoma
- Elizabeth Lee, MD, Dana Farber Cancer Institute Mentored Investigator GrantPhase II Trial of Gemcitabine+ATR Inhibitor: Translational Studies
- Jianhuang Lin, PhD, The Wistar Institute Mentored Investigator GrantTargeting ER Stress Pathway in CARM1-Expressing Ovarian Cancer
- Ignacio Vázquez-García, PhD, Memorial Sloan Kettering Cancer Center Mentored Investigator GrantCo-Evolution and Dynamics of Malignant and Immune Cells in Ovarian Cancer
- Sohrab Shah, PhD, Memorial Sloan Kettering Cancer Center Collaborative Research Development GrantProfiling Co-Evolution of Ovarian Cancer and its Immune Microenvironment
2019 Grant Recipients
- Sarah Gitto, PhD, University of Pennsylvania Mentored Investigator GrantModeling Autologous TIL Therapy in Novel PARP Resistant PDX Model for Ovarian Cancer
- Isaac Klein, MD, PhD, Dana Farber Cancer Institute Mentored Investigator GrantTranscriptional Regulatory Landscape of High Grade Serous Ovarian Cancer
- Elaine Stur, PhD, MD Anderson Cancer Center Mentored Investigator GrantRe-activating Anti-tumor Immunity Targeting PSEN1 in CAFS in Ovarian Cancer
- Haineng Xu, PhD, University of Pennsylvania Mentored Investigator GrantA Novel Targeted Therapy for Cyclin E Over Expressing Ovarian Cancers
- Kate Lawrenson, PhD, Cedars-Sinai Medical Center Early Career Investigator GrantElucidating the Role of SOX17 in HGSOC
- Kris Wood, PhD, Duke University Early Career Investigator GrantPrecision Targeting of Altered Mitochondrial States in Ovarian Cancer
- Zvi Yaari, PhD, Memorial Sloan Kettering Cancer Center Mentored Investigator GrantImplantable Nanosensor for Early-Stage Detection of Ovarian Cancer
- Rugang Zhang, PhD, The Wistar Institute Collaborative Research Development GrantDeveloping Epigenetic Therapies for Ovarian Cancer
2018 Grant Recipients
- Matthew Dean, PhD, University of Illinois - Chicago Mentored Investigator GrantThe Ovarian Microenvironment in Metastasis of Fallopian Tube Derived Cancer
- Sarah Stuckelberger, MD, University of Pennsylvania Mentored Investigator GrantDevelopment of A Novel Syngeneic Model System for Ovarian Cancer Research
- Sumegha Mitra, PhD, Indiana University Early Career Investigator GrantUCHL1 Regulates Oncogenic Signaling in Ovarian Cancer
- Shuang Zhang, PhD, New York University School of Medicine Mentored Investigator GrantModeling Human HGSOC Using Fallopian Tube Organoid Cultures